Literature DB >> 7882633

Women in clinical drug trials. An update.

D L Schmucker1, M S O'Mahony, E S Vesell.   

Abstract

Entities:  

Keywords:  Biomedical and Behavioral Research; National Institutes of Health

Mesh：

Year:  1994        PMID： 7882633     DOI： 10.2165/00003088-199427060-00002

Source DB:  PubMed          Journal:  Clin Pharmacokinet        ISSN： 0312-5963            Impact factor:   6.447


× No keyword cloud information.
  37 in total

1.  Medication during pregnancy: an intercontinental cooperative study. Collaborative Group on Drug Use in Pregnancy (C.G.D.U.P.).

Authors: 
Journal:  Int J Gynaecol Obstet       Date:  1992-11       Impact factor: 3.561

2.  NIH called to task: women needed in clinical trials.

Authors:  D A Tisevich
Journal:  J Natl Cancer Inst       Date:  1990-07-18       Impact factor: 13.506

3.  Sex differences in the management of coronary artery disease. Survival and Ventricular Enlargement Investigators.

Authors:  R M Steingart; M Packer; P Hamm; M E Coglianese; B Gersh; E M Geltman; J Sollano; S Katz; L Moyé; L L Basta
Journal:  N Engl J Med       Date:  1991-07-25       Impact factor: 91.245

4.  Spontaneous reporting of adverse drug reactions. II: Uses.

Authors:  M D Rawlins
Journal:  Br J Clin Pharmacol       Date:  1988-07       Impact factor: 4.335

5.  Problems in clinical trials go far beyond misconduct.

Authors:  R Nowak
Journal:  Science       Date:  1994-06-10       Impact factor: 47.728

6.  Women in clinical trials of new drugs. A change in Food and Drug Administration policy. The Working Group on Women in Clinical Trials.

Authors:  R B Merkatz; R Temple; S Subel; K Feiden; D A Kessler
Journal:  N Engl J Med       Date:  1993-07-22       Impact factor: 91.245

7.  Sedatives and hypnotics in Stockholm: social factors and kinds of use.

Authors:  G Blennow; A Romelsjö; H Leifman; A Leifman; G Karlsson
Journal:  Am J Public Health       Date:  1994-02       Impact factor: 9.308

8.  [Prevalence and sociodemographic correlates of benzodiazepine utilization in an urban population].

Authors:  G Pakesch; H Katschnig; R Dittrich; N Loimer; E Rasinger; G Tutsch
Journal:  Nervenarzt       Date:  1993-05       Impact factor: 1.214

9.  Underrepresentation of women in new drug trials.

Authors:  E L Kinney; J Trautmann; J A Gold; E S Vesell; R Zelis
Journal:  Ann Intern Med       Date:  1981-10       Impact factor: 25.391

10.  Linking prescription and patient-identifying data: a pilot study.

Authors:  S F Hurley; J J McNeil; D J Jolley; R Harvey
Journal:  Med J Aust       Date:  1992-03-16       Impact factor: 7.738
View more
  3 in total

Review 1.  A two way view of gender bias in medicine.

Authors:  M T Ruiz; L M Verbrugge
Journal:  J Epidemiol Community Health       Date:  1997-04       Impact factor: 3.710

Review 2.  Gender effects in pharmacokinetics and pharmacodynamics.

Authors:  R Z Harris; L Z Benet; J B Schwartz
Journal:  Drugs       Date:  1995-08       Impact factor: 9.546

Review 3.  Reviewing the role of healthy volunteer studies in drug development.

Authors:  Joyson J Karakunnel; Nam Bui; Latha Palaniappan; Keith T Schmidt; Kenneth W Mahaffey; Briggs Morrison; William D Figg; Shivaani Kummar
Journal:  J Transl Med       Date:  2018-12-04       Impact factor: 5.531
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.